Sodium Phosphates (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Sodium Phosphates drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
SUBSTANCE NAME: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2000-09-06
END MARKETING DATE: 0000-00-00


Sodium Phosphates HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Phosphates from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 276; 142(mg/mL; mg/mL)
START MARKETING DATE: 2000-09-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-170_4bd4e702-5560-4abb-a142-b06940698cb2
PRODUCT NDC: 63323-170
APPLICATION NUMBER:

Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthSodium Phosphates
Fresenius Kabi USA, LLCSodium Phosphates
Hospira, Inc.Sodium Phosphates
Salix Pharmaceuticals, Inc.OsmoPrep